Vanilloid receptors: New insights enhance potential as a therapeutic target

Pain

Volumn 68, Issue 2-3, 1996, Pages 195-208

  Szallasi, Arpad ^a,c   Blumberg, Peter M ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NATIONAL CANCER INSTITUTE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

capsaicin; messenger plasticity; neurogenic inflammation; neuropathic pain; resiniferatoxin; vanilloid receptors

Indexed keywords

CAPSAICIN; RESINIFERATOXIN; UNCLASSIFIED DRUG; VANILLOID; VANILLOID RECEPTOR;

ANTINOCICEPTION; HUMAN; LIGAND BINDING; NERVOUS SYSTEM INFLAMMATION; NEUROPATHY; PAIN; PRIORITY JOURNAL; REVIEW;

ANIMALS; CAPSAICIN; DITERPENES; DOWN-REGULATION; HUMANS; RATS; RECEPTORS, CELL SURFACE; RECEPTORS, DRUG; STRUCTURE-ACTIVITY RELATIONSHIP; UP-REGULATION;

EID: 0030443812     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(96)03202-2     Document Type: Review

References (177)

1. 3H]resiniferatoxin binding by the vanilloid (capsaicin) receptor in dorsal root ganglia, spinal cord, dorsal vagal complex, sciatic and vagal nerve and urinary bladder of the rat, Life Sci., 55 (1994) 1017-1026.
2. Acs, G., Lee, J., Marquez, V.E., Wang, S., Milne, G.W.A., Du, L., Lewin, N.E. and Blumberg, P.M., Resiniferatoxin-amide and analogues as ligands for protein kinase C and vanilloid receptors and determination of their biological activities as vanilloids, J. Neurochem., 65 (1995) 301-308.
3. 45Ca uptake and for high affinity binding in cultured rat dorsal root ganglion neurons and dorsal root ganglion membranes, Mol. Brain Res., 35 (1996) 173-182.
4. Amann, R. and Maggi, C.A., Ruthenium red as a capsaicin antagonist, Life Sci., 49 (1991) 849-856.
5. Anand, P., Gibson, S.J., McGregor, G.P., Blank, M.A., Christofides, N.D., Polak, J.M. and Bloom, S.R., Peripheral neuronal systems show marked increases in VIP/PHI and CCK content following injury, Regul. Peptides, 7 (1983) 273-281.
6. Anand, P., Gibson, S.J., Scaravilli, F., Blank, M.A., McGregor, G.P., Appenzeller, O., Dhital, K., Polak, J.M. and Bloom, S.R., Studies of vasoactive intestinal polypeptide expression in injured peripheral neurons using capsaicin, sympathectomy and mf mutant rats, Neurosci. Lett., 118 (1990) 61-66.
7. Appendino, G., Cravotto, G., Palmisano, G., Annunziata, R. and Szallasi, A., Synthesis and evaluation of phorboid 20-homovanillates: discovery of a class of ligands binding to the vanilliod (capsaicin) receptor with different degrees of cooperativity. J. Med. Chem., 39 (1996) 3123-3131.
8. Auberson, S. and Lundberg, J.M., Lactic acid-induced plasma protein extravasation in rat airways by stimulation of sensory nerves and NK1 receptor activation, Pharmacol. Toxicol., 73 (1993) 305-310.
9. Barbanti, G., Maggi, C.A., Beneforti, P. and Turini, D., Relief of pain following intravesical capsaicin in patients with hypersensitive disorders of the lower urinary tract, Br. J. Urol., 71 (1993) 686-695.
10. Bascom, R., Kagey-Sobotka, A. and Proud, D., Effect of intranasal capsaicin on symptoms and mediator release, J. Pharmacol. Exp. Ther., 259 (1991) 1323-1327.
11. Bennett, G.J., Neuropathic pain. In: P.D. Wall and R. Melzack (Eds.), Textbook of Pain, Churchill Livingstone, Edinburgh, 1994, pp. 201-224.
12. Bernstein, J.E., Korman, N.J., Bickers, D.R., Dahl, M.V. and Millikan, L.E., Topical capsaicin treatment of chronic postherpetic neuralgia, J. Am. Acad. Dermatol., 21 (1989) 265-270.
13. Bevan, S. and Geppetti, P., Protons: small stimulants of capsaicin-sensitive sensory nerves, Trends Neurosci., 17 (1994) 509-512.
14. Bevan, S. and Szolcsányi, J., Sensory neurone-specific actions of capsaicin: mechanisms and applications, Trends Pharmacol. Sci., 11 (1990) 330-333.
15. Bevan, S. and Yeats, J., Protons activate a cation conductance in a sub-population of rat dorsal root ganglion neurones, J. Physiol. (London), 433 (1991) 145-161.
16. Bevan, S., James, I.F., Rang, H.P., Winter, J. and Wood, J.N., The mechanism of action of capsaicin: a sensory neurotoxin. In: P. Jenner (Ed.), Neurotoxins and their Pharmacological Applications, Raven Press, New York, 1987, pp. 261-277.
17. Bevan, S., Hothi, S., Hughes, G., James, I.F., Rang, H.P., Shah, K., Walpole, C.S.J. and Yeats, J.C., Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin, Br. J. Pharmacol., 107 (1992) 544-552.
18. Bleakman, D., Brorson, J.R. and Miller, R.J., The effect of capsaicin on voltage-gated calcium currents and calcium signals in cultured dorsal root ganglion cells, Br. J. Pharmacol., 101 (1990) 423-431.
19. Blumberg, P.M., Szallasi, A. and Acs, G., Resiniferatoxin: an ultrapotent capsaicin analogue. In: J.N. Wood (Ed.), Capsaicin in the Study of Pain, Academic Press, New York, 1993, pp. 45-62.
20. Brand, L.M., Skare, K.L., Loomans, M.E., Reller, H.H., Schwen, R.J., Lade, D.A., Bohne, R.L., Maddin, C.S., Moorehead, D.P., Fanelli, R., Chiabrando, C., Castelli, M.G. and Tai, H.H., Antiinflammatory pharmacology and mechanism of the orally active capsaicin analogs, NE-19950 and NE-28345, Agents Actions, 31 (1990) 329-340.
21. Buck, S.H. and Burks, T.F., The neuropharmacology of capsaicin: a review of some recent observations, Pharmacol. Rev., 38 (1986) 179-226.
22. Camazine, S., Resch, J., Eisner, T. and Meinwald, J., Mushroom chemical defence: pungent sesquiterpenoid dialdehyde antifeedant to opossum, J. Chem. Ecol., 9 (1983) 1439-1447.
23. Cameron-Smith, D., Colquhoun, E.Q., Ye, J.M., Hettiarachchi, M. and Clark, M.G., Capsaicin and dihydrocapsaicin stimulate oxygen consumption in the perfused rat hindlimb, Int. J. Obes., 4 (1990) 259-270.
24. Capsaicin Study Group, Treatment of painful diabetic neuropathy with topical capsaicin: a multi-centre, double-blind, vehicle-controlled study. Arch. Intern. Med., 151 (1991) 2225-2229.
25. Carter, R.B., Topical capsaicin in the treatment of cutaneous disorders, Drug Dev. Res., 22 (1991) 109-123.
26. Cheshire, W.P. and Snyder, C.R., Treatment of reflex sympathetic dystrophy with topical capsaicin: case report, Pain, 42 (1990) 307-311.
27. Cholewinski, A., Burgess, G.M. and Bevan, S., The role of calcium in capsaicin-induced desensitization in rat cultured dorsal root ganglion neurons, Neuroscience, 55 (1993) 1015-1023.
28. Chung, J.M., Lee, K.H., Hori, Y. and Willis, W.D., Effects of capsaicin applied to a peripheral nerve on the responses of primate spinothalamic tract cells, Brain Res., 329 (1985) 27-38.
29. Cimino, G., Sodano, G. and Spinella, A., Correlation of the reactivity of 1,4-dialdehydes with methylamine in biomimetic conditions with their hot taste: covalent binding to primary amines as a molecular mechanism in hot taste receptors, Tetrahedron, 43 (1987) 5401-5410.
30. Clarke, I.M.C., Peppering pain, Lancet, 342 (1993) 1130.
31. Coderre, T.J., Katz, J., Vaccarino, A.L. and Melzack, R., Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence, Pain, 52 (1993) 259-285.
32. Collier, J.G. and Fuller, R.W., Capsaicin inhalation in man and effects of sodium chromoglycate, Br. J. Pharmacol., 81 (1984) 113-117.
33. 2) receptors in perfused rat hindlimb, Life Sci., 57 (1995) 91-102.
34. Devor, M., Nerve pathophysiology and mechanisms of pain in causalgia, J. Autonomic Nerv. Syst., 7 (1983) 371-384.
35. Devor, M. and Raber, P., Heritability of symptoms in an experimental model of neuropathic pain, Pain, 42 (1990) 51-67.
36. Dickenson, A.H. and Dray, A., Selective antagonism of capsaicin by capsazepine: evidence for a spinal receptor site in capsaicin-induced antinociception, Br. J. Pharmacol., 104 (1991) 1045-1049.
37. Docherty, R.J., Robertson, B. and Bevan, S., Capsaicin causes prolonged inhibition of voltage-activated calcium currents in adult rat dorsal root ganglion neurons in culture. Neuroscience, 40 (1991) 513-521.
38. Dray, A., Neuropharmacological mechanisms of capsaicin and related substances, Biochem. Pharmacol., 44 (1992) 611-615.
39. Dray, A., Bettaney, J. and Forster, P., Action of capsaicin on peripheral nociceptors of the neonatal rat spinal cord-tail in vitro: dependence of extracellular ions and independence of second messengers, Br. J. Pharmacol., 101 (1990) 727-733.
40. Dubner, R., Neuronal plasticity and pain following peripheral tissue inflammation or nerve injury. In: M.R. Bond, J.E. Charlton and C.J. Woolf (Eds.), Pain Research and Clinical Management, Vol. 4, Proc. VIth World Congress on Pain, Elsevier, Amsterdam, 1991a, pp. 263-276.
41. Dubner, R., Topical capsaicin therapy for neuropathic pain, Pain, 47 (1991b) 247-248.
42. Eldershaw, T.P.D., Colquhoun, E.Q., Dora, K.A., Peng, Z.-C. and Clark, M.G., Pungent principles of ginger (Zingiber officinale) are thermogenic in the perfused rat hindlimb, Int. J. Obes., 16 (1992) 755-763.
43. Eldershaw, T.P.D., Colquhoun, E.Q., Bennett, K.L., Dora, K.A. and Clark, M.G., Resiniferatoxin and piperine: capsaicin-like stimulators of oxygen uptake in the perfused rat hindlimb, Life Sci., 55 (1994) 389-397.
44. Farkas-Szallasi, T., Lundberg, J.M., Wiesenfeld-Hallin, Zs., Hökfelt, T. and Szallasi, A., Increased levels of GMAP, VIP and nitric oxide synthase, and their mRNAs, in lumbar dorsal root ganglia of the rat following systemic resiniferatoxin treatment, NeuroReport, 6 (1995) 2230-2234.
45. Farkas-Szallasi, T., Bennett, G.J., Blumberg, P.M., Hökfelt, T., Lundberg, J.M. and Szallasi, A., Vanilloid receptor loss is independent of the messenger plasticity that follows systemic resiniferatoxin administration, Brain Res., 719 (1996) 213-218.
46. Filiaci, F., Zambetti, G., Ciofalo, A., Luce, M., Masieri, S. and Lovecchio, A., Local treatment of aspecific nasal hyperreactivity with capsaicin, Allergol. Immunopathol., 22 (1994) 264-268.
47. Fitzgerald, M., Alterations in the ipsi- and contralateral afferent inputs of dorsal horn cells produced by capsaicin treatment of one sciatic nerve in the rat. Brain Res., 248 (1982) 97-107.
48. Fitzgerald, M., Wall, P.D., Goedert, M. and Emson, P.C., Nerve growth factor counteracts the neurophysiological and neurochemical effects of chronic sciatic nerve section, Brain Res., 332 (1985) 131-141.
49. Fowler, C.J., Jewkes, D., McDonald, W.I., Lynn, B. and de Groat, W.C., Intravesical capsaicin for neurogenic bladder dysfunction, Lancet, 339 (1992) 1239.
50. Franco-Cereceda, A. and Lundberg, J.M., Capsazepine inhibits low pH- and lactic acid-evoked release of calcitonin gene-related peptide from sensory nerves in guinea-pig heart, Eur. J. Pharmacol., 221 (1992) 183-186.
51. Friedrich, E.G., Therapeutic studies on vulvar vestibulities, J. Reprod. Med., 33 (1988) 514-518.
52. Gamse, R., Capsaicin and nociception in the rat and mouse: possible role of substance P, Naunyn-Schmiedeberg's Arch. Pharmacol., 320 (1982) 205-216.
53. Gamse, R., Petsche, U., Lembeck, F. and Jancsó, G., Capsaicin applied to the peripheral nerve inhibits axoplasmic transport of substance P and somatostatin, Brain Res., 238 (1982) 447-462.
54. Garcia-Hirschfeld, J., López-Briones, L.G., Belmonte, C. and Valdeol-millos, M., Intracellular free calcium responses to protons and capsaicin in cultured trigeminal neurons, Neuroscience, 67 (1995) 235-243.
55. Gasparovic, I., Hadzovic, S., Hukovic, S. and Stern, P., Contribution to the theory that substance P has a transmitter role in sensitive pathway, Med. Exp., 10 (1964) 303-306.
56. Geirsson, G., Fall, M. and Sullivan, L., Clinical and urodynamic effects of intravesical capsaicin treatment in patients with chronic traumatic spinal detrusor hyperreflexia, J. Urol., 154 (1995) 1825-1829.
57. Geppetti, P., Fusco, B.M., Marabini, S., Maggi, C.A., Fanciullacci, M. and Sicuteri, F., Secretion, pain and sneezing induced by the application of capsaicin to the nasal mucosa in man, Br. J. Pharmacol., 93 (1988) 509-514.
58. Goso, C., Piovacari, G. and Szaliasi, A., Resiniferatoxin-induced loss of vanilloid receptors is reversible in the urinary bladder but not in the spinal cord of the rat, Neurosci. Lett., 165 (1994) 101-104.
59. Greiff, L., Svensson, C., Andersson, M. and Persson, C.G.A., Effects of topical capsaicin in seasonal allergic rhinitis. Thorax, 50 (1995) 225-229.
60. 2), Life Sci., 59 (1996) 105-117.
61. Hao, J.-X., Yu, W., Xu, X.-J. and Wiesenfeld-Hallin, Zs., Capsaicin sensitive afferents mediate chronic cold, but not mechanical, allodynia-like behaviour in spinally injured rats. Brain Res., 122 (1996) 177-180.
62. Hayes, A.G. and Tyers, M.B., Effects of capsaicin on nociceptive heat, pressure and chemical threshold and on substance P levels in the rat, Brain Res., 189 (1980) 561-564.
63. Hayes, A.G., Oxford, A., Reynolds, M., Shingler, A.H., Skingle, M., Smith, C. and Tyers, M.B., The effects of a series of capsaicin analogs on nociception and body temperature in the rat, Life Sci., 34 (1984) 1241-1248.
64. Heike, C.J., DiMicco, J.A., Jacobowitz, D.M. and Kopin, I.J., Effects of capsaicin administration to neonatal rats on the substance P content of discrete CNS regions, Brain Res., 222 (1981) 428-431.
65. Herdegen, T., Fiallos-Estrada, C.E., Schmid, W., Bravo, R. and Zimmermann, M., The transcription factors c-JUN, JUN D and CREB, but not FOS and KROX-24, are differentially regulated in axotomized neurons following transection of rat sciatic nerve, Mol. Brain Res., 14 (1992) 155-165.
66. Herdegen, T., Fiallos-Estrada, C.E., Bravo, R. and Zimmermann, M., Colocalisalion and covariation of c-JUN transcription factor with galanin in primary afferent neurons and with CGRP in spinal moto-neurons following transection of rat sciatic nerve, Mol. Brain Res., 17 (1993) 147-154.
67. Holzer, P., Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons, Pharmacol. Rev., 43 (1991) 144-201
68. Holzer, P., Jurna, I., Gamse, R. and Lembeck, F., Nociceptive threshold after neonatal capsaicin treatment, Eur. J. Pharmacol., 58 (1979) 511-514.
69. Hökfelt, T., Wiesenfeld-Hailin, Zs., Villar, M. and Melander, T., Increase of galanin-like immunoreactivity in rat dorsal root ganglion cells after peripheral axotomy. Neurosci. Lett., 83 (1987) 217-220.
70. Hökfelt, T., Zhang, X. and Wiesenfeld-Hailin, Zs., Messenger plasticity in primary sensory neurons following axotomy and its functional implications, Trends Neurosci., 17 (1994) 22-30.
71. Ingram, S.L., Martenson, M.E. and Baumann, T.K., Responses of cultured adult monkey trigeminal ganglion neurons to capsaicin, NeuroReport, 4 (1993) 460-462.
72. Jancsó, N., Speicherung. Stoffanreicherung im Retikuloendothel und in der Niere. Akadémiai Kiadö, Budapest. 1955.
73. Jancsó, N., Role of nerve terminals in the mechanism of inflammatory reactions. Bull. Millard Fillmore Hosp., 7 (1960) 53-77.
74. Jancsó, N., Desensitization with capsaicin and related acylamides as a tool for studying the function of pain receptors. In: K. Lin, D. Armstrong and E.G. Pardo (Eds.), Pharmacology of Pain, Pergamon Press. Oxford, 1968, pp. 33-55.
75. Jancsó, G., Sensory nerves as modulators of inflammatory reactions. In: L.A. Chahl, J. Szolcsányi and F. Lembeck (Eds.), Antidromic Vasodilatation and Neurogenic Inflammation, Akadémiai Kiadó, Budapest, 1984, pp. 207-222.
76. Jancsó, G., Pathobiological reactions of C-fibre primary sensory neurones to peripheral nerve injury, Exp. Physiol., 77 (1992) 405-431.
77. Jancsó, N. and Jancsó-Gábor, A., Desensitization of sensory nerve endings (in Hungarian), Kísérl. Orvostud., 2 (Suppl.) (1949) 15.
78. Jancsó, G. and Lawson, S.N., Ganglionic changes associated with trans-ganglionic degeneration of capsaicin-sensitive primary sensory afferents: a quantitative morphometric and immunohistochemical study, Regul. Peptides, 22 (1988) 97.
79. Jancsó, G. and Lynn, B., Possible use of capsaicin in pain therapy, Clin. J. Pain. 3 (1987) 123-126.
80. Jancsó, G., Király, E. and Jancsó-Gábor, A., Pharmacologically induced selective degeneration of chemosensitive sensory neurons, Nature, 270 (1978) 741-743.
81. Jancsó, G., Hökfelt, T., Lundberg, J.M., Király, E., Halász, N., Nilsson, G., Terenius, L., Rehfeld, J., Steinbusch, H., Verhofstad, A., Elde, R., Said, S. and Brown, M., Immunohistochemical studies on the effect of capsaicin on spinal and medullary peptide and monoamine neurons using antisera to substance P, gastrin/CCK, somatostatin, VIP, enkephalin, neurotensin and 5-hydroxytryptamine, J. Neurocytol., 10 (1981) 963-980.
82. Janusz, J.M., Buckwalter, B.L., Young, P.A., LaHann, T.R., Farmer, R.W., Kasting, G.B., Loomans, M.E., Kerckaert, G.A., Maddin, C.S., Berman, E.F., Bohne, R.L., Cupps, T.L. and Milstein, J.R., Vanilloids, 1: analogs of capsaicin with antinociceptive and antiinflammatory activity, J. Med. Chem., 36 (1993) 2595-2604.
83. Jeftinija, S., Liu, F., Jeftinija, K. and Urban, L., Effect of capsaicin and resiniferatoxin on peptidergic neurons in cultured dorsal root ganglion, Regul. Peptides, 39 (1992) 123-135.
84. Jenkins, R. and Hunt, S.P., Long-term increase in the levels of c-jun mrRNA and Jun protein-like immunoreactivity in motor and sensory neurons following axon damage, Neurosci. Lett., 129 (1991) 107-110.
85. Jessell, T.M., Iversen, L.L. and Cuello, A.C., Capsaicin-induced depletion of substance P from primary sensory neurones, Brain Res., 152 (1978) 183-188.
86. Kawakami, T., Hikawa, N., Kusakabe, T., Kano, M., Bandou, Y., Gotoh, H. and Takenaka, T., Mechanism of inhibitory action of capsaicin on particulate axoplasmic transport in sensory neurons in culture, J. Neurobiol., 24 (1993) 545-551.
87. Khasar, S.G. and Levine, J.D., Neonatal capsaicin attenuates mechanical nociception in the rat, Neurosci. Lett., 205 (1996) 141-143.
88. 2+ channels in isolated rat trigeminal and hippocampal neurones, NeuroReport, 6 (1995) 2338-2340.
89. Kubo, I. and Ganjian, I., Insect antifeedant terpenes, hot-tasting to humans, Experientia, 37 (1981) 1063-1064.
90. Lacroix, J.S., Buvelot, J.M., Polla, B.S. and Lundberg, J.M., Improvement of symptoms of non-allergic chronic rhinitis by local treatment with capsaicin, Clin. Exp. Allergy, 21 (1991) 595-602.
91. Leah, J.D., Herdegen, T. and Bravo, R., Selective expression of Jun proteins following axotomy and axonal transport block in peripheral nerves in the rat: evidence for a role in the regeneration process, Brain Res., 566 (1991) 198-207.
92. Leibsohn, E., Treatment of notalgia paresthetica with topical capsaicin, Cutis, 49 (1992) 335-336.
93. Lemheck, F. and Donnerer, J., Time course of capsaicin-induced functional impairments in comparison with changes in neuronal substance P content, Naunyn-Schmiedeberg's Arch. Pharmacol., 316 (1981) 240-243.
94. Lindahl, O., Experimental skin pain, Acta Physiol. Scand., 51 (Suppl.) (1961) 179.
95. Lindsay, R.M. and Harmar, A.J., Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurones, Nature, 337 (1989) 362-364.
96. Liu, L. and Simon, S.A., A rapid capsaicin-activated current in rat trigeminal ganglion neurons, Proc. Natl. Acad. Sci. USA, 91 (1994) 738-741.
97. 2+ dependence in rat trigeminal ganglion cells, J. Neurophysiol., 75 (1996) 1503-1514.
98. Liu, L., Wang, Y. and Simon, S.A., Capsaicin activated currents in rat dorsal root ganglion cells, Pain, 64 (1996) 191-195.
99. Low, P.A., Opfer-Gehrking, T.L., Dyck, P.J., Litchy, W.J. and O'Brian, P.C., Double-blind, placebo-controlled study of the application of capsaicin cream in chronic distal painful polyneuropathy, Pain, 62 (1995) 163-168.
100. Lundberg, J.M. and Saria, A., Capsaicin-induced desensitization of the airway mucosa to cigarette smoke, mechanical and chemical irritants, Nature, 302 (1983) 251-253.
101. Lynn, B., Capsaicin: actions on nociceptive C-fibers and therapeutic potential, Pain, 41 (1990) 61-69.
102. Maggi, C.A., The pharmacology of the efferent function of sensory nerves, J. Autonomic Pharmacol., 11 (1991) 173-208.
103. Maggi, C.A., Therapeutic potential of capsaicin-like molecules: studies in animals and humans, Life Sci., 51 (1992) 1777-1781.
104. Maggi, C.A. and Meli, A., The sensory-efferent function of capsaicin-sensitive sensory neurons, Gen. Pharmacol., 19 (1988) 1-43.
105. Maggi, C.A., Patacchini, R., Tramontana, M., Amann, R., Giuliani, S. and Santicioli, S., Similarities and differences in the action of resiniferatoxin and capsaicin on central and peripheral endings of primary sensory neurons, Neuroscience, 37 (1990) 531-539.
106. Maggi, C.A., Bevan, S., Walpole, C.S.J., Rang, H.P. and Giuliani, S., A comparison of capsazepine and ruthenium red as a capsaicin antagonist in the rat isolated urinary bladder and vas deferens, Br. J. Pharmacol., 108 (1993) 801-805.
107. Marsh, S.H., Stansfeld, C.E., Brown, D.A., Davey, R. and McCarthy, D., The mechanism of action of capsaicin on sensory C-type neurons and their axons in vitro, Neuroscience, 23 (1987) 275-290.
108. Marabini, S., Ciabatti, P.G., Polli, G., Fusco, B.M. and Geppetti, P., Beneficial effects of intranasal applications of capsaicin in patients with vasomotor rhinitis, Eur. Arch. Otorhinolaryngol., 248 (1991) 191-194.
109. Martenson, M.E., Ingram, S.L. and Baumann, T.K., Potentiation of rabbit trigeminal responses to capsaicin in a low pH environment, Brain Res., 651 (1994) 143-147.
110. Meller, S.T., Gebhart, G.F. and Maves, T.J., Neonatal capsaicin treatment prevents the development of the thermal hyperalgesia produced in a model of neuropathic pain in the rat, Pain, 51 (1992) 317-321.
111. Midgren, B., Hansson, L., Karlsson, J.-A., Simonsson, B.G. and Persson, C.G.A., Capsaicin-induced cough in man, Am. Rev. Resp. Dis., 146 (1992) 347-351.
112. Miller, M.S., Buck, S.H., Sipes, I.G., Yamamura, H.I. and Burks, T.F., Regulation of substance P by nerve growth factor: disruption by capsaicin, Brain Res., 250 (1982) 193-196.
113. Monsereenosurn, Y., Kongsamut, S. and Pezalla, P.D., Capsaicin: a literature survey, CRC Crit. Rev. Toxicol., 10 (1982) 321-339.
114. Morgenlander, J.C., Hurwitz, B.J. and Massey, E.W., Capsaicin for the treatment of pain in Guillain-Barré syndrome, Ann. Neurol., 28 (1990) 199.
115. Nagy, J.I. and van der Kooy, D., Effects of neonatal capsaicin treatment on nociceptive threshold in the rat, J. Neurosci., 3 (1983) 1145-1150.
116. Nagy, J.I., Vincent, S.R., Staines, W.A., Fibiger, H.C., Reisine, T.D. and Yamamura, H.I., Neurotoxic action of capsaicin on spinal substance P neurons, Brain Res., 186 (1980) 435-444.
117. Nielsch, U. and Keen, P., Reciprocal regulation of tachykinin- and vasoactive intestinal polypeptide-gene expression in rat sensory neurones following cut and crush injury, Brain Res., 481 (1989) 25-30.
118. Noguchi, K., Senba, E., Morita, Y., Sata, M. and Tohyama, M., PreproVIP and preprotachykinin mRNAs in the dorsal root ganglion cells following peripheral axotomy, Mol. Brain Res., 6 (1989) 327-330.
119. Obál, Jr., F., Benedek, G., Jancsó-Gábor, A. and Obál, F., Salivary cooling, escape reaction, and heat pain in capsaicin-desensitized rats, Pflügers Arch., 382 (1979) 249-254.
120. Oh, U., Hwang, S.W. and Kim, D., Capsaicin activates a nonselective cation channel in cultured neonatal rat dorsal root ganglion neurons, J. Neurosci., 16 (1996) 1659-1667.
121. Petersen, M. and LaMotte, R.H., Relationships between capsaicin sensitivity of mammalian sensory neurons, cell size and type of voltage gated Ca currents, Brain Res., 561 (1991) 20-26.
122. Persson, C.G.A. and Erjefält, I., Inflammatory leakage of macromolecules from the vascular compartment into the tracheal lumen, Acta Physiol. Scand., 126 (1986) 615-616.
123. Prechtl, J.C. and Powley, T.L., B-afferents: a fundamental division of the nervous system mediating homeostasis?, Behavior. Brain Sci., 13 (1990) 289-300.
124. Rang, H.P., The nociceptive afferent neurone as a target for new types of analgesic drugs. In: M.R. Bond, J.L. Charlton and C.J. Woolf (Eds.), Pain Research and Clinical Management, Proc. VIth World Congress on Pain, Elsevier, Amsterdam, 1991, pp. 119-127.
125. Rang, H.P., Bevan, S. and Dray, A., Nociceptive peripheral neurons: cellular properties. In: P.D. Wall and R. Melzack (Eds.), Textbook of Pain, Churchill Livingstone, Edinburgh, 1994, pp. 57-78.
126. Rao, M.S., Sun, Y., Escary, J.L., Perreau, J., Tresser, S., Patterson, P.H., Zigmond, R.E., Brulet, P. and Landis, S.C., Leukemia inhibitory factor mediates an injury response not a target-directed developmental transmitter switch in sympathetic neurons, Neuron, 11 (1993) 1175-1185.
127. Ross, D.R. and Varipapa, R.J., Treatment of painful diabetic neuropathy with topical capsaicin, N. Engl. J. Med., 321 (1989) 474-475.
128. Rumsfield, J.A. and West, D.P., Topical capsaicin in dermatologic and peripheral disorders, DICP Ann. Pharmacother., 25 (1991) 381-387.
129. Santicioli, P., Del Bianco, E., Figini, M., Bevan, S. and Maggi, C.A., Effect of capsazepine on the release of calcitonin gene-related peptide-like (CGRP-LI) immunoreactivity induced by low pH, capsaicin and potassium in rat soleus muscle, Br. J. Pharmacol., 110 (1993) 609-612.
130. Shuster, S., Capsaicin and the cause of causalgia, Lancet, 345 (1995) 160-161.
131. Skofitsch, G., Zamir, N., Helke, C.J., Savitt, J.M. and Jacobowitz, D.M., Corticotropin releasing factor-like immunoreactivity in sensory ganglia and capsaicin sensitive neurons of the rat central nervous system: colocalization with other neuropeptides, Peptides, 6 (1985) 307-318.
132. Stanfa, L., Dickenson, A., Xu, X.-J. and Wiesenfeld-Hallin, Zs., Cholecystokinin and morphine analgesia: variations on a theme, Trends Pharmacol. Sci., 15 (1994) 65-66.
133. Steen, K.H., Reeh, P.W., Anton, F. and Handwerker, H.O., Protons selectively induce lasting excitation and sensitization to mechanical stimulation of nociceptors in rat skin, in vitro, J. Neurosci., 12 (1992) 86-99.
134. Stjärne, P., Lundblad, L., Lundberg, J.M. and Änggård, A., Capsaicin and nicotine sensitive afferent neurons and nasal secretion in healthy human volunteers and in patients with vasomotor rhinitis, Br. J. Pharmacol., 96 (1989) 693-701.
135. Sterner, O. and Anke, H., Toxic terpenoids isolated from higher fungi, Czech Mycol., 48 (1995) 39-52.
136. Surh, Y.-J. and Lee, S.S., Capsaicin, a double-edged sword: toxicity, metabolism, and chemopreventive potential, Life Sci., 56 (1995) 1845-1855.
137. Szallasi, A., The vanilloid (capsaicin) receptor: receptor types and species differences, Gen. Pharmacol., 25 (1994) 223-243.
138. Szallasi, A., Autoradiographic visualization and pharmacological characterization of vanilloid (capsaicin) receptors in several species, including man, Acta Physiol. Scand., 155 (Suppl.) (1995) 629.
139. Szallasi, A., Vanilloid-sensitive neurons: a fundamental subdivision of the peripheral nervous system, J. Periph. Nerv. Syst., 1 (1996) 6-18.
140. Szallasi, A. and Blumberg, P.M., Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper, Neuroscience, 30 (1989) 515-520.
141. Szallasi, A. and Blumberg, P.M., Specific binding of resiniferatoxin, an ultrapotent capsaicin analog, by dorsal root ganglion membranes, Brain Res., 524 (1990a) 106-111.
142. Szallasi, A. and Blumberg, P.M., Resiniferatoxin and its analogs provide novel insights into the pharmacology of the vanilloid (capsaicin) receptor, Life Sci., 47 (1990b) 1399-1408.
143. Szallasi, A. and Blumberg, P.M., Molecular target size of the vanilloid (capsaicin) receptor. Life Sci., 48 (1991) 1863-1869.
144. Szallasi, A. and Blumberg, P.M., Vanilloid receptor loss in rat sensory ganglia associated with long term desensitization to resiniferatoxin, Neurosci. Lett., 136 (1992) 51-54.
145. Szallasi, A. and Blumberg, P.M., Mechanisms and therapeutic potential of vanilloids (capsaicin-like molecules), Adv. Pharmacol., 24 (1993) 123-155.
146. Szallasi, A., Sharkey, N.A. and Blumberg, P.M., Structure-activity analysis of resiniferatoxin analogs, Phytother. Res., 3 (1989) 253-257.
147. Szallasi, A., Lewin, N.E. and Blumberg, P.M., Vanilloid (capsaicin) receptor in the rat: positive cooperativity of resiniferatoxin binding and its modulation by reduction and oxidation, J. Pharmacol. Exp. Ther., 266 (1993) 678-683.
148. 3H]resiniferatoxin autoradiography of capsaicin-sensitive neurons in the rat, pig, and man, Eur. J. Pharmacol., 264 (1994) 217-221.
149. 3H]resiniferatoxin binding to vanilloid (capsaicin) receptors in rat spinal cord, Eur. J. Pharmacol. Mol. Pharmacol. Sect., 289 (1995a) 181-187.
150. Szallasi, A., Nilsson, S., Farkas-Szallasi, T., Blumberg, J.M., Hökfelt, T. and Lundberg, J.M., Vanilloid (capsaicin) receptors in the rat: distribution in the brain, regional differences in the spinal cord, axonal transport to the periphery, and depletion by systemic vanilloid treatment, Brain Res., 703 (1995b) 175-183.
151. Szallasi, A., Acs, G., Cravotto, G., Blumberg, P.M., Lundberg, J.M. and Appendino, G., A novel agonist, phorbol 12-phenylacetate 13-acetate 20-homovanillate, abolishes positive cooperativity of binding by the vanilloid receptor, Eur. J. Pharmacol., 299 (1996a) 221-228.
152. Szallasi, A., Jonassohn, M., Ács, G., Bíró, T., Ács, P., Blumberg, P.M. and Sterner, O., The stimulation of capsaicin-sensitive neurones in a vanilloid receptor-mediated fashion by pungent terpenoids possessing an unsaturated 1,4-dialdehyde moiety, Br. J. Pharmacol., 119 (1996b) 283-290.
153. Szallasi, A., Farkas-Szallasi, T., Tucker, J.B., Lundberg, J.M., Hokfelt, T. and Krause, J.E., Systemic resiniferatoxin decreases mRNAs encoding SP in lumbar DRGs of the rat but not the number of SP-positive sensory neurons, Soc. Neurosci. Abst., 22 (1996c) 345.12.
154. Szolcsányi, J., Capsaicin and neurogenic inflammation: history and early findings. In: L.A. Chahl, J. Szolcsányi and F. Lembeck (Eds.), Antidromic Vasodilatation and Neurogenic Inflammation, Akadémiai Kiadö, Budapest, 1984, pp. 6-25.
155. Szołcsányi, J., Perspectives of capsaicin-type agents in pain therapy and research. In: W.C.V. Parris (Ed.), Contemporary Issues in Chronic Pain Management, Kluwer Academic, Boston, 1991, pp. 97-124.
156. Szolcsányi, J. and Jancsó-Gábor, A., Sensory effects of capsaicin congeners, I: relationship between chemical structure and pain-producing potency, Drug Res., 25 (1975) 1877-1881.
157. Szolcsányi, J. and Jancsó-Gábor, A., Sensory effects of capsaicin congeners, II: importance of chemical structure and pungency in desensitizing activity of capsaicin-type compounds, Drug Res., 26 (1976) 33-37.
158. Szolcsányi, J., Szallasi, A., Szallasi, Z., Joó, F. and Blumberg, P.M., Resiniferatoxin, an ultrapotent selective modulator of capsaicin-sensitive primary afferent neurons, J. Pharmacol. Exp. Ther., 255 (1990) 923-928.
159. Taylor, D.C.M., Pierau, Fr.-K. and Szolcsányi, J., Long-lasting inhibition of horseradish peroxidase (HRP) transport in sensory nerves induced by capsaicin pretreatment of the receptive field, Brain Res., 298 (1984) 45-49.
160. Verge, V.M.K., Richardson, P.M., Wiesenfeld-Hallin, Zs. and Hökfelt, T., Differential influence of nerve growth factor in neuropeptide expression in vivo: a novel role in peptide suppression in adult sensory neurons, J. Neurosci., 15 (1995) 2081-2096.
161. Virus, R.M. and Gebhart, G.F., Pharmacologic actions of capsaicin: apparent involvement of substance P and serotonin, Life Sci., 25 (1979) 1273-1284.
162. Wall, P.D., Devor, M., Inbal, R., Scadding, J.W., Schonfeld, J., Seltzer, Z. and Tomkiewicz, M.M., Autotomy following peripheral nerve lesions: experimental anaesthesia dolorosa, Pain, 7 (1979) 103-113.
163. Wallengren, J., Treatment of notalgia paresthetica with topical capsaicin, J. Am. Acad. Dermatol., 24 (1991) 286-288.
164. Wallengren, J. and Klinker, M., Successful treatment of notalgia paresthetica with topical capsaicin: vehicle-controlled, double-blind, crossover study, J. Am. Acad. Dermatol., 32 (1995) 287-289.
165. Walpole, C.S.J., Wrigglesworth, R., Bevan, S., Campbell, E.A., Dray, A., James, I.F., Perkins, M.N., Reid, D.R. and Winter, J., Analogues of capsaicin with agonist activity as novel analgesic agents; structure-activity studies, I : the aromatic 'A-region', J. Med. Chem., 36 (1993a) 2362-2372.
166. Walpole, C.S.J., Wrigglesworth, R., Bevan, S., Campbell, E.A., Dray, A., James, I.F., Masdin, K.J., Perkins, M.N. and Winter, J., Analogues of capsaicin with agonist activity as novel analgesic agents; structure-activity studies, 2: the amide bond 'B-region', J. Med. Chem., 36 (1993b) 2373-2380.
167. Walpole, C.S.J., Wrigglesworth, R., Bevan, S., Campbell, E.A., Dray, A., James, I.F., Masdin, K.J., Perkins, M.N. and Winter, J., Analogues of capsaicin with agonist activity as novel analgesic agents; structure-activity studies, 3: the hydrophobic side-chain 'C-region', J. Med. Chem., 36 (1993c) 2381-2389.
168. Walpole, C.S.J., Bevan, S., Bloomfield, G., Breckenridge, R., James, I.F., Ritchie, T., Szallasi, A., Winter, J. and Wrigglesworth, R., Similarities and differences in the structure-activity relationships of capsaicin and resiniferatoxin analogues, J. Med. Chem., 39 (1996) 2939-2952.
169. Watson, C.P.N., Evans, R.J. and Watt, V.R., Post-herpetic neuralgia and topical capsaicin, Pain, 33 (1988) 333-340.
170. Watson, C.P.N., Evans, R.J. and Watt, V.R., The post-mastectomy pain syndrome and the effect of topical capsaicin, Pain, 38 (1989) 177-186.
171. Williams, J.T. and Zieglgänsberger, W., The acute effects of capsaicin on rat primary afferents and spinal neurons, Brain Res., 253 (1982) 125-131.
172. Winter, J., Dray, A., Wood, J.N., Yeats, J.C. and Bevan, S., Cellular mechanism of action of resiniferatoxin: a potent sensory neuron excitotoxin, Brain Res., 520 (1990) 131-140.
173. Winter, J., Bevan, S. and Campbell, E.A., Capsaicin and pain mechanisms, Br. J. Anaesth., 75 (1995) 157-168.
174. Wood, J.N. (Ed.), Capsaicin in the Study of Pain, Academic Press, New York, 1993.
175. Wood, J.N., Lillycrop, K.A., Dent, C.L., Ninkina, N.N., Beech, M.M., Willoughby, J.J. and Latchman, D.S., Regulation of expression of the neuronal POU protein Oct-2 by NGF, J. Biol. Chem., 267 (1992) 17787-17791.
176. Xu, X.-J., Hao, J.-X., Aldskogius, H., Seiger, Å. and Wiesenfeld-Hallin, Zs., Chronic pain-related syndrome in rats after ischemic spinal cord lesion: a possible animal model for pain in patients with spinal cord injury, Pain, 48 (1992) 279-290.
177. Yeats, J.C., Boddeke, H.W.G.M. and Docherty, R.J., Capsaicin desensitization in rat dorsal root ganglion neurones is due to activation of calcineurin, Br. J. Pharmacol., 107 (Suppl.) (1992) 238P.